MeSH term
Frequency | Condition_Probility | Adult | 36 | 0.0 |
Aged | 39 | 0.0 |
Female | 71 | 0.0 |
Humans | 213 | 0.0 |
Immunohistochemistry | 71 | 0.0 |
Male | 67 | 0.0 |
Microtubule-Associated Proteins/*immunology | 7 | 100.0 |
Middle Aged | 42 | 0.0 |
Research Support, Non-U.S. Gov't | 154 | 0.0 |
Animals | 118 | 0.0 |
Binding Sites | 7 | 0.0 |
Cattle | 14 | 0.0 |
Comparative Study | 35 | 0.0 |
Cytoskeleton/*metabolism | 4 | 3.0 |
Mice | 30 | 0.0 |
Microtubule-Associated Proteins/chemistry/*metabolism | 2 | 20.0 |
Models, Biological | 4 | 0.0 |
Models, Molecular | 2 | 0.0 |
Mutation | 3 | 0.0 |
Protein Binding | 13 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Rats | 50 | 0.0 |
Recombinant Fusion Proteins/chemistry/metabolism | 2 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 91 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 10 | 0.0 |
Disease Models, Animal | 6 | 0.0 |
English Abstract | 9 | 0.0 |
Aged, 80 and over | 23 | 0.0 |
Antibodies | 3 | 0.0 |
Microtubule-Associated Proteins/immunology/*metabolism | 4 | 100.0 |
Phosphorylation | 33 | 0.0 |
Prospective Studies | 3 | 0.0 |
Molecular Sequence Data | 38 | 0.0 |
Mutagenesis | 2 | 0.0 |
Alzheimer Disease/metabolism/*pathology | 3 | 9.0 |
Amyloid beta-Protein/metabolism | 2 | 3.0 |
Brain/metabolism/*pathology | 3 | 9.0 |
Dendrites/metabolism/*pathology | 2 | 40.0 |
Microtubule-Associated Proteins/metabolism | 23 | 16.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 13 | 0.0 |
Amino Acid Sequence | 32 | 0.0 |
CHO Cells | 5 | 0.0 |
COS Cells | 3 | 0.0 |
Cells, Cultured | 24 | 0.0 |
Cercopithecus aethiops | 2 | 0.0 |
Hamsters | 8 | 0.0 |
Adolescent | 15 | 0.0 |
Child | 18 | 0.0 |
Child, Preschool | 12 | 0.0 |
Glial Fibrillary Acidic Protein/biosynthesis | 2 | 10.0 |
Infant | 14 | 0.0 |
Microscopy, Confocal | 6 | 0.0 |
Microtubule-Associated Proteins/biosynthesis | 2 | 11.0 |
*Nerve Tissue Proteins | 7 | 1.0 |
Arcuate Nucleus/*pathology | 3 | 75.0 |
Brain/*pathology | 3 | 1.0 |
Brain Injuries/*pathology | 2 | 33.0 |
Hypoglossal Nerve/*pathology | 3 | 75.0 |
Neurons/pathology | 5 | 4.0 |
Cell Count | 4 | 0.0 |
Cell Differentiation/physiology | 4 | 0.0 |
Phenotype | 6 | 0.0 |
Action Potentials/physiology | 2 | 4.0 |
Fetus | 6 | 1.0 |
Immunoblotting | 11 | 0.0 |
Microtubule-Associated Proteins/*metabolism | 22 | 20.0 |
Neurons/*metabolism/pathology | 2 | 3.0 |
Neuroglia/metabolism | 2 | 2.0 |
Neurons/metabolism | 3 | 0.0 |
Tubulin/metabolism | 12 | 12.0 |
Blotting, Western | 12 | 0.0 |
Cell Division | 3 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Cytoskeleton/metabolism | 3 | 1.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
*Drosophila Proteins | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Microscopy, Fluorescence | 3 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Neuroblastoma/metabolism | 3 | 5.0 |
Subcellular Fractions/metabolism | 2 | 0.0 |
Transfection | 16 | 0.0 |
Tumor Cells, Cultured | 19 | 0.0 |
Microtubule-Associated Proteins/analysis | 17 | 47.0 |
Schizophrenia/*pathology | 4 | 30.0 |
Microtubule-Associated Proteins/genetics | 4 | 10.0 |
Neurofilament Proteins/genetics | 2 | 15.0 |
Neurons/*pathology | 2 | 3.0 |
Risk Factors | 2 | 0.0 |
Neurofilament Proteins/analysis | 5 | 23.0 |
Silver Staining | 2 | 2.0 |
Drug Evaluation, Preclinical | 2 | 1.0 |
Microtubules/drug effects/metabolism | 2 | 15.0 |
Alzheimer Disease/genetics/*metabolism | 2 | 7.0 |
Antibody Specificity | 4 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Epitopes | 3 | 0.0 |
Fluorescent Antibody Technique, Indirect | 3 | 0.0 |
Neurofibrillary Tangles/metabolism/pathology | 2 | 15.0 |
Protein Conformation | 6 | 0.0 |
Fluorescent Antibody Technique | 10 | 0.0 |
Microscopy, Electron | 12 | 0.0 |
Neuronal Plasticity/*physiology | 2 | 4.0 |
Cell Culture Techniques/*methods | 3 | 3.0 |
Neurofilament Proteins/metabolism | 4 | 7.0 |
Postmortem Changes | 2 | 2.0 |
Rats, Sprague-Dawley | 9 | 0.0 |
Time Factors | 6 | 0.0 |
*Bacterial Proteins | 2 | 1.0 |
Biological Markers/analysis | 3 | 0.0 |
Neurons/drug effects/metabolism/*pathology | 2 | 100.0 |
Phosphopyruvate Hydratase/metabolism | 2 | 3.0 |
Tetradecanoylphorbol Acetate/pharmacology | 3 | 0.0 |
Tretinoin/pharmacology | 2 | 0.0 |
Antibodies, Monoclonal | 9 | 0.0 |
Gestational Age | 6 | 0.0 |
Neurons/drug effects/*metabolism | 2 | 5.0 |
Pregnancy | 12 | 0.0 |
Sheep | 2 | 0.0 |
Alternative Splicing | 4 | 0.0 |
Kinetics | 16 | 0.0 |
Microtubules/metabolism | 6 | 5.0 |
Repetitive Sequences, Amino Acid | 2 | 1.0 |
Paclitaxel/*pharmacology | 2 | 3.0 |
Rats, Wistar | 5 | 0.0 |
Reference Values | 3 | 0.0 |
Phosphoric Monoester Hydrolases/metabolism | 3 | 3.0 |
tau Proteins/metabolism | 11 | 16.0 |
Apoptosis/*physiology | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Glial Fibrillary Acidic Protein/analysis | 7 | 4.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Nerve Tissue Proteins/genetics | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Autoradiography | 2 | 0.0 |
Cell Differentiation | 7 | 0.0 |
Cell Line | 27 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Transplantation, Heterologous | 2 | 0.0 |
Immunoenzyme Techniques | 8 | 0.0 |
Brain Stem/*metabolism/pathology | 2 | 40.0 |
Dendrites/*pathology | 2 | 40.0 |
Microtubule-Associated Proteins/*analysis | 10 | 47.0 |
Hippocampus/metabolism | 2 | 2.0 |
Microtubules/physiology/ultrastructure | 2 | 40.0 |
Morphogenesis | 2 | 0.0 |
Neuronal Plasticity | 2 | 7.0 |
Phosphoprotein Phosphatase/metabolism | 5 | 6.0 |
Protein Kinases/metabolism | 7 | 1.0 |
*Protein Processing, Post-Translational | 2 | 0.0 |
Microtubules/*metabolism | 5 | 6.0 |
Alzheimer Disease/*metabolism/pathology | 3 | 3.0 |
Base Sequence | 13 | 0.0 |
Gene Expression | 5 | 0.0 |
Hippocampus/metabolism/pathology | 2 | 6.0 |
Neuroblastoma | 3 | 1.0 |
Organ Specificity | 5 | 0.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 13 | 0.0 |
Microtubule-Associated Proteins/*chemistry | 4 | 33.0 |
Embryo | 3 | 0.0 |
Enzyme Activation | 8 | 0.0 |
Enzyme Inhibitors/pharmacology | 3 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Cell Count/methods | 2 | 3.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Neurons/metabolism/*pathology | 4 | 13.0 |
Olivary Nucleus/*pathology | 2 | 50.0 |
Autopsy | 2 | 1.0 |
Cause of Death | 2 | 1.0 |
Antigens, CD/analysis | 3 | 0.0 |
Antigens, Differentiation, Myelomonocytic/analysis | 2 | 0.0 |
Neurons/*metabolism | 8 | 2.0 |
*Disease Models, Animal | 2 | 0.0 |
Histocytochemistry | 6 | 0.0 |
Alzheimer Disease/*metabolism | 4 | 1.0 |
tau Proteins/analysis | 2 | 14.0 |
DNA Primers | 5 | 0.0 |
Dogs | 3 | 0.0 |
Ehrlichia chaffeensis/genetics/*immunology | 2 | 66.0 |
Epitopes/analysis | 4 | 1.0 |
Restriction Mapping | 4 | 0.0 |
Spinal Cord/*metabolism | 2 | 6.0 |
Dendrites/*metabolism/ultrastructure | 2 | 22.0 |
Infant, Newborn | 6 | 0.0 |
Microtubule-Associated Proteins/*biosynthesis | 6 | 27.0 |
Virulence Factors, Bordetella/pharmacology | 2 | 1.0 |
*Alternative Splicing | 2 | 0.0 |
Brain/*metabolism | 3 | 0.0 |
Chickens | 3 | 0.0 |
Antibodies, Monoclonal/immunology | 3 | 0.0 |
Biological Markers | 4 | 0.0 |
Brain Chemistry | 4 | 1.0 |
Drug Resistance, Neoplasm | 2 | 0.0 |
Mice, Nude | 2 | 0.0 |
Tubulin/*metabolism | 4 | 12.0 |
tau Proteins/*metabolism | 4 | 8.0 |
Cell Survival/physiology | 3 | 1.0 |
Hippocampus/cytology | 2 | 5.0 |
Rats, Inbred Strains | 3 | 0.0 |
Cell Differentiation/drug effects | 4 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 3 | 0.0 |
Neuropeptides/analysis | 2 | 10.0 |
Biological Transport/physiology | 2 | 1.0 |
Nerve Tissue Proteins/metabolism | 4 | 1.0 |
Diagnosis, Differential | 3 | 0.0 |
Cell Survival/*drug effects | 2 | 2.0 |
Paclitaxel/pharmacology | 3 | 3.0 |
In Situ Hybridization | 5 | 0.0 |
Cytoskeletal Proteins/metabolism | 2 | 0.0 |
Cell Compartmentation | 2 | 0.0 |
Peptide Fragments/chemistry | 2 | 1.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Neurons/*physiology | 3 | 2.0 |
Hippocampus/*metabolism | 3 | 4.0 |
Microtubules/drug effects/*physiology | 2 | 22.0 |
Intermediate Filament Proteins/analysis | 3 | 7.0 |
Nerve Tissue Proteins/*analysis | 2 | 2.0 |
Retrospective Studies | 3 | 0.0 |
Vimentin/analysis | 4 | 1.0 |
Axons/physiology | 3 | 6.0 |
Microtubule-Associated Proteins/*biosynthesis/genetics | 2 | 15.0 |
Alzheimer Disease/*metabolism/*pathology | 2 | 10.0 |
Embryonic and Fetal Development/physiology | 2 | 2.0 |
Microtubules/*physiology/ultrastructure | 2 | 25.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Substrate Specificity | 11 | 0.0 |
Swine | 6 | 0.0 |
*Postmortem Changes | 2 | 9.0 |
Temperature | 2 | 0.0 |
Tissue Distribution | 4 | 0.0 |
Microtubule-Associated Proteins/*physiology | 4 | 17.0 |
tau Proteins/pharmacology | 2 | 100.0 |
Binding, Competitive | 2 | 0.0 |
Microtubules/*metabolism/ultrastructure | 3 | 37.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Hela Cells | 8 | 0.0 |
Aluminum/*toxicity | 2 | 66.0 |
Rabbits | 3 | 0.0 |
Cloning, Molecular | 9 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Escherichia coli/metabolism | 2 | 0.0 |
Microtubule-Associated Proteins/*genetics/metabolism | 2 | 14.0 |
Erythrocytes/enzymology | 2 | 0.0 |
In Vitro | 2 | 0.0 |
Molecular Structure | 2 | 0.0 |
Aging | 2 | 0.0 |
Infant, Premature | 2 | 1.0 |
Neurons/*cytology/physiology | 2 | 20.0 |
Cell Division/drug effects | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/drug effects | 2 | 0.0 |
Molecular Weight | 16 | 0.0 |
Epithelial Cells | 2 | 0.0 |
Axons/pathology | 2 | 6.0 |
Neurons/metabolism/pathology | 4 | 5.0 |
Animals, Newborn | 3 | 0.0 |
Cytoskeletal Proteins/*analysis | 2 | 12.0 |
Neurons/chemistry/*ultrastructure | 2 | 33.0 |
Gene Expression Regulation | 2 | 0.0 |
Microtubule-Associated Proteins/*analysis/genetics | 2 | 25.0 |
Gene Library | 2 | 0.0 |
Species Specificity | 7 | 0.0 |
Glial Fibrillary Acidic Protein/metabolism | 5 | 2.0 |
Immunohistochemistry/methods | 4 | 0.0 |
Insulin/pharmacology | 3 | 1.0 |
Intermediate Filament Proteins/metabolism | 3 | 6.0 |
Microtubule-Associated Proteins/*genetics | 2 | 3.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Phosphatidylinositols/*metabolism | 2 | 2.0 |
Chromosome Mapping | 3 | 0.0 |
Pedigree | 2 | 0.0 |
Dendrites/metabolism | 2 | 11.0 |
Neurons/*chemistry | 2 | 6.0 |
Tubulin/*analysis | 3 | 75.0 |
Cross-Linking Reagents | 2 | 0.0 |
Microtubule-Associated Proteins/*analysis/metabolism | 2 | 50.0 |
Antigens, CD34/metabolism | 2 | 0.0 |
Nerve Growth Factors/metabolism | 2 | 3.0 |
Vimentin/metabolism | 2 | 1.0 |
Microtubule-Associated Proteins/genetics/*metabolism | 2 | 5.0 |
Microscopy, Immunoelectron | 3 | 0.0 |
Peptide Mapping | 3 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
*Signal Transduction | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Microtubules/*ultrastructure | 2 | 33.0 |
Staining and Labeling | 2 | 0.0 |
DNA/metabolism | 3 | 0.0 |
Nerve Tissue Proteins/*biosynthesis | 2 | 6.0 |
Dendrites/*metabolism | 2 | 20.0 |
Tyrosine/metabolism | 2 | 0.0 |
Cohort Studies | 2 | 0.0 |
Treatment Outcome | 2 | 0.0 |
Cytoskeletal Proteins/*metabolism | 2 | 1.0 |
Dendrites/metabolism/pathology | 2 | 100.0 |
DNA | 2 | 0.0 |
Precipitin Tests | 3 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase | 6 | 16.0 |
Leukemia, Promyelocytic, Acute | 2 | 3.0 |
Protein Kinases/*metabolism | 3 | 0.0 |
Olivopontocerebellar Atrophies/*metabolism/pathology | 2 | 100.0 |
*Brain Chemistry | 4 | 2.0 |
Clone Cells | 2 | 0.0 |
Tretinoin/*pharmacology | 2 | 0.0 |
Neurites/ultrastructure | 2 | 13.0 |
Alzheimer Disease/*immunology/pathology | 3 | 37.0 |
Epitopes/immunology | 2 | 0.0 |
Intermediate Filaments/*immunology | 3 | 60.0 |
Dementia/metabolism/pathology | 2 | 33.0 |
Hippocampus/*metabolism/pathology | 2 | 5.0 |
Intermediate Filament Proteins/*analysis | 3 | 15.0 |
Alzheimer Disease/*pathology | 2 | 3.0 |
Protein Kinases/*isolation & purification/metabolism | 2 | 100.0 |
Repetitive Sequences, Nucleic Acid | 3 | 0.0 |
tau Proteins | 10 | 58.0 |
Antibodies/immunology | 3 | 0.0 |
Chromatography, Ion Exchange | 3 | 0.0 |
*Mitogen-Activated Protein Kinases | 2 | 0.0 |
Microfilaments/metabolism/ultrastructure | 2 | 33.0 |
Neurofilament Proteins | 6 | 27.0 |
Antibodies, Monoclonal/diagnostic use | 3 | 0.0 |
Chromatography, DEAE-Cellulose | 2 | 3.0 |
Chromatography, Gel | 3 | 0.0 |
Fibroblasts/enzymology | 2 | 1.0 |
Cell Differentiation/drug effects/physiology | 2 | 2.0 |
Cell Line, Tumor | 3 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Immunosorbent Techniques | 2 | 0.0 |
Membrane Proteins/immunology/*metabolism | 2 | 7.0 |
Synaptophysin | 2 | 20.0 |
Cyclic AMP/pharmacology | 2 | 1.0 |
Nucleic Acid Hybridization | 4 | 0.0 |
DNA/*genetics | 2 | 0.0 |
Brain/metabolism | 3 | 0.0 |
Cytoskeletal Proteins/analysis | 2 | 4.0 |
Cytoskeleton/*immunology | 2 | 16.0 |
Neurofibrils/*immunology/ultrastructure | 2 | 100.0 |
Supranuclear Palsy, Progressive/*immunology/pathology | 2 | 100.0 |
Epitopes/*analysis | 2 | 1.0 |
Cross Reactions | 3 | 0.0 |
Immunoassay | 2 | 0.0 |
Chymotrypsin/metabolism | 2 | 5.0 |
Intermediate Filament Proteins/immunology | 2 | 25.0 |
Immunologic Techniques | 3 | 0.0 |
Mitosis | 2 | 0.0 |
Microtubule-Associated Proteins | 3 | 33.0 |
Proteins/*analysis | 2 | 1.0 |
Mice, Transgenic | 2 | 0.0 |
Microtubule-Associated Proteins/drug effects/metabolism | 2 | 25.0 |
